Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis

Advanced Drug Delivery Reviews

Volumn 54, Issue 11, 2002, Pages 1373-1393

  Ferrari, Stefano ^a   Geddes, Duncan M ^a   Alton, Eric W F W ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Barriers; Cystic fibrosis; Gene therapy; Non viral vector; Virus

Indexed keywords

GENE TRANSFER; GENES; RESPIRATORY MECHANICS;

GENE THERAPY;

GENETIC ENGINEERING;

RECOMBINANT DNA; VIRUS VECTOR;

AIRWAY; CELL SURFACE; CYSTIC FIBROSIS; DNA DEGRADATION; DNA VECTOR; DRUG EFFICACY; DRUG PENETRATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; METHODOLOGY; MUCUS; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY EPITHELIUM; REVIEW; TRANSGENE;

EID: 0037027911     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00145-X     Document Type: Article

References (136)

1. Zabner J., Couture L.A., Gregory R.J., Graham S.M., Smith A.E., Welsh M.J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelium of patients with cystic fibrosis. Cell. 75:1993;207-216.
2. Crystal R.G., McElvaney N.G., Rosenfeld M.A., Chu C.S., Mastrangeli A., Hay J.G., Brody S.L., Jaffe H.A., Eissa N.T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:1994;42-51.
3. Hay J.G., McElvaney N.G., Herena J., Crystal R.G. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA gene transfer vector. Hum. Gene Ther. 6:1995;1487-1496.
4. Knowles M.R., Hohneker K., Zhou Z., Olsen J.C., Noah T.L., Hu P.C., Leigh M.W., Engelhardt J.F., Edwards L.J., Jones K.R., Grossman M., Wilson J.M., Johnson L.G., Boucher R.C. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. 333:1995;823-831.
5. Zabner J., Ramsey B.W., Meeker D.P., Aitken M.L., Balfour R.P., Gibson R.L., Launspach J., Moscicki R.A., Richards S.M., Standaert T.A., Williams-Warren J., Wadsworth S.C., Smith A.E., Welsh M.J. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97:1996;1504-1511.
6. Bellon G., Michel-Calemard L., Thouvenot D., Jagneaux V., Poitevin F., Malcus C., Accart N., Layani M.P., Aymard M., Bernon H., Bienvenu J., Courtney M., Doring G., Gilly B., Gilly R., Lamy D., Levrey H., Morel Y., Paulin C., Perraud F., Rodillon L., Sené C., So S., Touraine-Moulin F., Schatz C., Pavirani A. Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum. Gene Ther. 8:1997;15-25.
7. Harvey B.G., Leopold P.L., Hackett N.R., Grasso T.M., Williams P.M., Tucker A.L., Kaner R.J., Ferris B., Gonda I., Sweeney T.D., Ramalingam R., Kovesdi I., Shak S., Crystal R.G. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest. 104:1999;1245-1255.
8. Zuckerman J.B., Robinson C.B., McCoy K.S., Shell R., Sferra T.J., Chirmule N., Magosin S.A., Propert K.J., Brown-Parr E.C., Hughes J.V., Tazelaar J., Baker C., Goldman M.J., Wilson J.M. A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum. Gene Ther. 10:1999;2973-2985.
9. Perricone M.A., Morris J.E., Pavelka K., Plog M.S., O'Sullivan B.P., Joseph P.M., Dorkin H., Lapey A., Balfour R., Meeker D.P., Smith A.E., Wadsworth S.C., St. George J.A. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium. Hum. Gene Ther. 12:2001;1383-1394.
10. Wagner J.A., Reynolds T., Moran M.L., Moss R.B., Wine J.J., Flotte T.R., Gardner P. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet. 351:1998;1702-1703.
11. Aitken M.L., Moss R.B., Waltz D.A., Dovey M.E., Tonelli M.R., McNamara S.C., Gibson R.L., Ramsey B.W., Carter B.J., Reynolds T.C. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12:2001;1907-1916.
12. Caplen N.J., Alton E.W.F.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D.J., Williamson R., Geddes D.M. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1:1995;39-46.
13. Zabner J., Cheng S.H., Meeker D., Launspach J., Balfour R., Perricone M.A., Morris J.E., Marshall J., Fasbender A., Smith A.E., Welsh M.J. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 100:1997;1529-1537.
14. Gill D.R., Southern K.W., Mofford K.A., Seddon T., Huang L., Sorgi F., Thomson A., MacVinish L.J., Ratcliff R., Bilton D., Lane D.J., Littlewood J.M., Webb A.K., Middleton P.G., Colledge W.H., Cuthbert A.W., Evans M.J., Higgins C.F., Hyde S.C. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;199-209.
15. Porteous D.J., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., Carothers A.D., Wallace W.A.H., Moralee S., Hoenes C., Kallmeyer G., Michaelis U., Naujoks K., Ho L.P., Samways J.M., Imrie M., Greening A.P., Innes J.A. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4:1997;210-218.
16. Alton E.W.F.W., Stern M., Farley R., Jaffe A., Chadwick S.L., Phillips J., Davies J., Smith S.N., Browning J., Davies M.G., Hodson M.E., Durham S.R., Li D., Jeffery P.K., Scallan M., Balfour R., Eastman S.J., Cheng S.H., Smith A.E., Meeker D., Geddes D.M. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet. 353:1999;947-954.
17. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., Gooi H.C., Goddard C.A., Hannavy K., Smyth S.E., Egan J.J., Sorgi F.L., Huang L., Cuthbert A.W., Evans M.J., Colledge W.H., Higgins C.F., Webb A.K., Gill D.R. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 7:2000;1156-1165.
18. Noone P.G., Hohneker K.W., Zhou Z., Johnson L.G., Foy C., Gipson C., Jones K., Noah T.L., Leigh M.W., Schwartzbach C., Efthimiou J., Pearlman R., Boucher R.C., Knowles M.R. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 1:2000;105-114.
19. Ruiz F.E., Clancy J.P., Perricone M.A., Bebok Z., Hong J.S., Cheng S.H., Meeker D.P., Young K.R., Schoumacher R.A., Weatherly M.R., Wing L., Morris J.E., Sindel L., Rosenberg M., Van Ginkel F.W., McGhee J.R., Kelly D., Lyrene R.K., Sorscher E.J. A clinical inflammatory syndrome attributable to aerosolised lipid-DNA administration in Cystic Fibrosis. Hum. Gene Ther. 12:2001;751-761.
20. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., Demeester J. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am. J. Respir. Crit. Care Med. 162:2000;1905-1911.
21. Sanders N.N., Van Rompaey E., De Smedt S.C., Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 164:2001;486-493.
22. Yonemitsu Y., Kitson C., Ferrari S., Farley R., Griesenbach U., Judd D., Steel R., Scheid P., Zhu J., Jeffery P.K., Kato A., Hasan M.K., Nagai Y., Masaki I., Fukumura M., Hasegawa M., Geddes D.M., Alton E.W. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat. Biotechnol. 18:2000;970-973.
23. Kitson C., Angel B., Judd D., Rothery S., Severs N.J., Dewar A., Huang L., Wadsworth S.C., Cheng S.H., Geddes D.M., Alton E.W.F.W. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 6:1999;534-546.
24. Ferrari S., Kitson C., Farley R., Steel R., Marriott C., Parkins D.A., Scarpa M., Wainwright B., Evans M.J., Colledge W.H., Geddes D.M., Alton E.W. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. 8:2001;1380-1386.
25. Stern M., Caplen N.J., Browning J.E., Griesenbach U., Sorgi F., Huang L., Gruenert D.C., Marriot C., Crystal R.G., Geddes D.M., Alton E.W.F.W. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 5:1998;91-98.
26. Perricone M.A., Rees D.D., Sacks C.R., Smith K.A., Kaplan J.M., St. George J.A. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum. Gene Ther. 11:2000;1997-2008.
27. Virella-Lowell I., Poirier A., Chesnut K.A., Brantly M., Flotte T.R. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther. 7:2000;1783-1789.
28. Ferrari S., Pettenazzo A., Garbati N., Zacchello F., Behr J.P., Scarpa M. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim. Biophys. Acta. 1447:1999;219-225.
29. Pickles R.J., Fahrner J.A., Petrella J.M., Boucher R.C., Bergelson J.M. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J. Virol. 74:2000;6050-6057.
30. Griesenbach U., Chonn A., Cassady R., Hannam V., Ackerley C., Post M., Tanswell A.K., Olek K., O'Brodovich H., Tsui L.C. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther. 5:1998;181-188.
31. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
32. Koehler D.R., Hannam V., Belcastro R., Steer B., Wen Y., Post M., Downey G., Tanswell A.K., Hu J. Targeting transgene expression for cystic fibrosis gene therapy. Mol. Ther. 4:2001;58-65.
33. Chirmule N., Propert K., Magosin S., Qian R., Wilson J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1999;1574-1583.
34. Harvey B.G., Hackett N.R., El-Sawy T., Rosengart T.K., Hirschowitz E.A., Lieberman M.D., Lesser M.L., Crystal R.G. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 73:1999;6729-6742.
35. Pickles R.J., Barker P.M., Ye H., Boucher R.C. Efficient adenovirus-mediated gene transfer to basal but not columnar cells of cartilaginous airway epithelia. Hum. Gene Ther. 7:1996;921-931.
36. Jiang C., O'Connor S.P., Fang S.L., Wang K.X., Marshall J., Williams J.L., Wilburn B., Echelard Y., Cheng S.H. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. 9:1998;1531-1542.
37. Matsui H., Johnson L.G., Randell S.H., Boucher R.C. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J. Biol. Chem. 272:1997;1117-1126.
38. Fasbender A., Zabner J., Zeiher B.G., Welsh M.J. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Ther. 4:1997;1173-1180.
39. Pickles R.J., McCarty D., Matsui H., Hart P.J., Randell S.H., Boucher R.C. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J. Virol. 72:1998;6014-6023.
40. Duan D., Yue Y., Yan Z., McCray P.B. Jr., Engelhardt J.F. Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum. Gene Ther. 9:1998;2761-2776.
41. Wang G., Zabner J., Deering C., Launspach J., Shao J., Bodner M., Jolly D.J., Davidson B.L., McCray P.B. Jr. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am. J. Respir. Cell Mol. Biol. 22:2000;129-138.
42. Chu Q., St. George J.A., Lukason M., Cheng S.H., Scheule R.K., Eastman S.J. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo. Hum. Gene Ther. 12:2001;455-467.
43. Parsons D.W., Grubb B.R., Johnson L.G., Boucher R.C. Enhanced in vivo airway gene transfer via transient modification of host barrier properties with a surface-active agent. Hum. Gene Ther. 9:1998;2661-2672.
44. Man Y., Hart V.J., Ring C.J.A., Sanjar S., West M.R. Loss of epithelial integrity resulting from E-cadherin dysfunction predisposes airway epithelial cells to adenoviral infection. Am. J. Respir. Cell Mol. Biol. 23:2000;610-617.
45. Coyne C.B., Kelly M.M., Boucher R.C., Johnson L.G. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23:2000;602-609.
46. Croyle M.A., Cheng X., Sandhu A., Wilson J.M. Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo. Mol. Ther. 4:2001;22-28.
47. Weiss D.J., Strandjord T.P., Jackson J.C., Clark J.G., Liggitt D. Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. Exp. Lung Res. 25:1999;317-333.
48. Weiss D.J., Bonneau L., Allen J.M., Miller A.D., Halbert C.L. Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lung. Mol. Ther. 2:2000;624-630.
49. Das A., Niven R. Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: implications for nebulized delivery of plasmids. J. Pharm. Sci. 90:2001;1336-1344.
50. Lee J.H., Baker T.J., Mahal L.K., Bertozzi C.R., Wiemer D.F., Welsh M.J. Engineering novel cell surface receptors for virus-mediated gene transfer. J. Biol. Chem. 274:1999;21878-21884.
51. Kreda S.M., Pickles R.J., Lazarowski E.R., Boucher R.C. G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecules ligands. Nat. Biotechnol. 18:2000;635-640.
52. R.J. Pickles, A.J. Hirsh, R.J. Gerard, R.C. Boucher, Retargeting Ad5 fibers to bradykinin receptors expressed on the lumenal surface of human airway epithelium, Pediatr. Pulmonol. Suppl. 22 (2001) Abstr. 215.
53. Drapkin P.T., O'Riordan C.R., Yi S.M., Chiorini J.A., Cardella J., Zabner J., Welsh M.J. Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J. Clin. Invest. 105:2000;589-596.
54. A.G. Ziady, T. Kelley, P.B. Davis, Molecular conjugate mediated CFTR gene transfer in CF mice affects secondary CF defects, Pediatr. Pulmonol. Suppl. 22 (2001) Abstr. 236.
55. Jost P.J., Harbottle R.P., Knight A., Miller A.D., Coutelle C., Schneider H. A novel peptide, THALWHT, for the targeting of human airway epithelia. FEBS Lett. 489:2001;263-269.
56. Wang G., Deering C., Macke M., Shao J., Burns R., Blau D.M., Holmes K.V., Davidson B.L., Perlman S., McCray P.B. Jr. Human coronavirus 229E infects polarized airway epithelia from the apical surface. J. Virol. 74:2000;9234-9239.
57. Slepushkin V.A., Staber P.D., Wang G., McCray P.B. Jr., Davidson B.L. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains. Mol. Ther. 3:2001;395-402.
58. Kobinger G.P., Weiner D.J., Yu Q.C., Wilson J.M. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:2001;225-230.
59. Kaplan J.M., Pennington S.E., St. George J.A., Woodworth L.A., Fasbender A., Marshall J., Cheng S.H., Wadsworth S.C., Gregory R.J., Smith A.E. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum. Gene Ther. 9:1998;1469-1479.
60. Fasbender A., Lee J.H., Walters R.W., Moninger T.O., Zabner J., Welsh M.J. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J. Clin. Invest. 102:1998;184-193.
61. Zabner J., Zeiher B.G., Friedman E., Welsh M.J. Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J. Virol. 70:1996;6994-7003.
62. Walters R.W., Yi S.M., Keshavjee S., Brown K.E., Welsh M.J., Chiorini J.A., Zabner J. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:2001;20610-20616.
63. L. Zhang, P.L. Collins, R.C. Boucher, R.J. Pickles, Respiratory syncytial virus (RSV) infects ciliated cells of airway epithelium via the lumenal membrane, Pediatr. Pulmonol. Suppl. 22 (2001) Abstr. 207.
64. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA. 92:1995;7297-7301.
65. Behr J.P. L'èponge à protons: un moyen d'entrer dans une cellule auquel les virus n'ont pas pensé Mèd. Sci. 12:1996;56-59.
66. Hansen J., Qing K., Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75:2001;4080-4090.
67. Yonemitsu Y., Kaneda Y., Muraishi A., Yoshizumi T., Sugimachi K., Sueishi K. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium. Gene Ther. 4:1997;631-638.
68. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., Beatty B., Squire J., O'Brodovich H., Lukacs G.L. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6:1999;482-497.
69. 2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J. Gene Med. 3:2001;153-164.
70. Duan D., Yue Y., Yan Z., Yang J., Engelhardt J.F. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105:2000;1573-1587.
71. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273:1998;7507-7511.
72. Tachibana R., Harashima H., Shinohara Y., Kiwada H. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv. Drug Deliv. Rev. 52:2001;219-226.
73. Sebestyen M.G., Ludtke J.J., Bassik M.C., Zhang G., Budker V., Lukhtanov E.A., Hagstrom J.E., Wolff J.A. DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. Nat. Biotechnol. 16:1998;80-85.
74. Zanta M.A., Belguise-Valladier P., Behr J.P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA. 96:1999;91-96.
75. Dean D.A. Peptide nucleic acids: versatile tools for gene therapy strategies. Adv. Drug Deliv. Rev. 44:2000;81-95.
76. Klink D.T., Chao S., Glick M.C., Scanlin T.F. Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells. Mol. Ther. 3:2001;831-841.
77. Whittaker G.R., Helenius A. Nuclear import and export of viruses and virus genomes. Virology. 246:1998;1-23.
78. Trotman L.C., Mosberger N., Fornerod M., Stidwill R.P., Greber U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3:2001;1092-1100.
79. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 101:2000;173-185.
80. Follenzi A., Ailles L.E., Bakovic S., Geuna M., Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:2000;217-222.
81. Jooss K., Yang Y., Wilson J.M. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7:1996;1555-1566.
82. Kolb M., Inman M., Margetts P.J., Galt T., Gauldie J. Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors. Am. J. Respir. Crit. Care Med. 164:2001;866-872.
83. Yang Y., Trinchieri G., Wilson J.M. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lungs. Nat. Med. 1:1995;890-893.
84. Chirmule N., Truneh A., Haecker S.E., Tazelaar J., Gao G., Raper S.E., Hughes J.V., Wilson J.M. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J. Immunol. 163:1999;448-455.
85. Scaria A., St. George J.A., Gregory R.J., Noelle R.J., Wadsworth S.C., Smith A.E., Kaplan J.M. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther. 4:1997;611-617.
86. Jooss K., Turka L.A., Wilson J.M. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig. Gene Ther. 5:1998;309-319.
87. Chirmule N., Raper S.E., Burkly L., Thomas D., Tazelaar J., Hughes J.V., Wilson J.M. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions. J. Virol. 74:2000;3345-3352.
88. O'Riordan C.R., Lachapelle A., Delgado C., Parkes V., Wadsworth S.C., Smith A.E., Francis G.E. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10:1999;1349-1358.
89. Chillon M., Lee J.H., Fasbender A., Welsh M.J. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 5:1998;995-1002.
90. Mack C.A., Song W.R., Carpenter H., Wickham T.J., Kovesdi I., Harvey B.G., Magovern C.J., Isom O.W., Rosengart T., Falck-Pedersen E., Hackett N.R., Crystal R.G., Mastrangeli A. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum. Gene Ther. 8:1997;99-109.
91. Croyle M.A., Chirmule N., Zhang Y., Wilson J.M. 'Stealth' adenovirus blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75:2001;4792-4801.
92. Beck S.E., Jones L.A., Chesnut K., Walsh S.M., Reynolds T.C., Carter B.J., Askin F.B., Flotte T.R., Guggino W.B. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol. 73:1999;9446-9455.
93. Halbert C.L., Rutledge E.A., Allen J.M., Russel D.W., Miller A.D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74:2000;1524-1532.
94. Manning W.C., Zhou S., Bland M.P., Escobedo J.A., Dwarki V. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum. Gene Ther. 9:1998;477-485.
95. Halbert C.L., Standaert T.A., Wilson C.B., Miller A.D. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J. Virol. 72:1998;9795-9805.
96. Zhang L., Wang D., Fischer H., Fan P.D., Widdicombe J.H., Kan Y.W., Dong J.Y. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc. Natl. Acad. Sci. USA. 95:1998;10158-10163.
97. Duan D., Yue Y., Engelhardt J.F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4:2001;383-391.
98. D. Duan, Y. Yue, J.F. Engelhardt, Expanding AAV packaging capacity with trans-splicing and overlapping vectors: A quantitative comparison, Pediatr. Pulmonol. Suppl. 22 (2001) Abstr. 221.
99. Goddard C.A., Ratcliff R., Anderson J.R., Glenn E., Brown S., Gill D.R., Hyde S.C., MacVinish L.J., Huang L., Higgins C.F., Cuthbert A.W., Evans M.J., Colledge W.H. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Ther. 4:1997;1231-1236.
100. Lee E.R., Marshall J., Siegel C.S., Jiang C., Yew N.S., Nichols M.R., Nietupski J.B., Ziegler R.J., Lane M.B., Wang K.X., Wan N.C., Scheule R.K., Harris D.J., Smith A.E., Cheng S.H. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7:1996;1701-1717.
101. Scheule R.K., St. George J.A., Bagley R.G., Marshall J., Kaplan J.M., Akita G.Y., Wang K.X., Lee E.R., Harris D.J., Jiang C., Yew N.S., Smith A.E., Cheng S.H. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8:1997;689-707.
102. Chadwick S.L., Kingston H.D., Stern M., Cook R.M., O'Connor B.J., Lukasson M., Balfour R.P., Rosenberg M., Cheng S.H., Smith A.E., Meeker D.P., Geddes D.M., Alton E.W. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Gene Ther. 4:1997;937-942.
103. Schwartz D.A., Quinn T.J., Thorne P.S., Sayeed S., Yi A.K., Krieg A.M. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:1997;68-73.
104. Yew N.S., Wang K.X., Przybylska M., Bagley R.G., Stedman M., Marshall J., Scheule R.K., Cheng S.H. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid: pDNA complexes. Hum. Gene Ther. 10:1999;223-234.
105. Yew N.S., Zhao H., Wu I.H., Song A., Tousignant J.D., Przybylska M., Cheng S.H. Reduced inflammatory responses to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1:2000;255-262.
106. Cassivi S.D., Liu M., Boehler A., Pierre A., Tanswell A.K., O'Brodovich H., Mullen J.B.M., Slutsky A.S., Keshavjee S.H. Transplant immunosuppression increases and prolongs transgene expression following adenoviral-mediated transfection of rat lungs. J. Heart Lung Transplant. 19:2000;984-994.
107. Scaria A., Sullivan J.A., St. George J.A., Kaplan J.M., Lukason M.J., Morris J.E., Plog M., Nicolette C., Gregory R.J., Wadsworth S.C. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates. Mol. Ther. 2:2000;505-514.
108. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., Hyde S.C. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter. Gene Ther. 8:2001;1539-1546.
109. Yew N.S., Przybylska M., Ziegler R.J., Liu D., Cheng S.H. High and sustained transgene expression in vivo from plasmid vector containing a hybrid ubiquitin promoter. Mol. Ther. 4:2001;75-82.
110. Yew N.S., Marshall J., Przybylska M., Wysokenski D.M., Ziegler R.J., Rafter P.W., Li C., Armentano D., Cheng S.H. Increased duration of transgene expression in the lung with plasmid DNA vectors harbouring adenovirus E4 open reading frame 3. Hum. Gene Ther. 10:1999;1833-1843.
111. 1-antitrypsin in mice. Mol. Ther. 4:2001;122-129.
112. Huertas D., Howe S., McGuigan A., Huxley C. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells. Hum. Mol. Genet. 9:2000;617-629.
113. Kearns W.G., Afione S.A., Fulmer S.B., Pang M.C., Erikson D., Egan M., Landrum M.J., Flotte T.R., Cutting G.R. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:1996;748-755.
114. Nakai H., Yant S.R., Storm T.A., Fuess S., Meuse L., Kay M.A. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75:2001;6969-6976.
115. Borthwick D.W., Shahbazian M., Todd Krantz Q., Dorin J.R., Randell S.H. Evidence for stem-cell niches in the tracheal epithelium. Am. J. Respir. Cell Mol. Biol. 24:2001;662-670.
116. Johnson L.G., Olsen J.C., Sarkadi B., Moore K.L., Swanstrom R., Boucher R.C. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2:1992;21-25.
117. Dorin J.R., Farley R., Webb S., Smith S.N., Farini E., Delaney S.J., Wainwright B.J., Alton E.W.F.W., Porteous D.J. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 3:1996;797-801.
118. Zhang Y., Jiang Q., Dudus L., Yankaskas J.R., Engelhardt J.F. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways. Hum. Gene Ther. 9:1998;635-648.
119. Gautam A., Densmore C.L., Golunski E., Xu B., Waldrep J.C. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol. Ther. 3:2001;551-556.
120. Schiavi S.C., Abdelkader N., Reber S., Pennington S., Narayana R., McPherson J.M., Smith A.E., Hoppe H. IV, Cheng S.H. Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am. J. Physiol. 270:1996;C341-C351.
121. Ye L., Chan S., Chow Y.H., Tsui L.C., Hu J. Regulated expression of the human CFTR gene in epithelial cells. Mol. Ther. 3:2001;723-733.
122. Goncz K.K., Colosimo A., Dallapiccola B., Gagné L., Homg K., Novelli G., Papahadjopoulos D., Sawa T., Schreier H., Wiener-Kronish J., Xu Z., Gruenert D.C. Expression of ΔF508 CFTR in normal lung after site-specific modification of CFTR sequences by SFHR. Gene Ther. 8:2001;961-965.
123. U. Griesenbach, B.T. Kren, M. Stern, R.L. Cassady, S. Jueliger, E. Hillery, R. Farley, D.M. Geddes, C.J. Steer, E.W. Alton, Conversion of wild-type CFTR to the G551D mutation in primary rat hepatocytes using RNA/DNA oligonucleotides, Pediatr. Pulmonol. Suppl. 22 (2001) Abstr. 231.
124. Friedman K.J., Kole J., Cohn J.A., Knowles M.R., Silverman L.M., Kole R. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides. J. Biol. Chem. 274:1999;36193-36199.
125. Lambert G., Becker B., Schreiber R., Boucherot A., Reth M., Kunzelmann K. Control of cystic fibrosis transmembrane conductance regulator expression by BAP31. J. Biol. Chem. 276:2001;20340-20345.
126. Mansfield S.G., Kole J., Puttaraju M., Yang C.C., Garcia-Blanco M.A., Cohn J.A., Mitchell L.G. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing. Gene Ther. 7:2000;1885-1895.
127. Liu X., Jiang Q., Mansfield S.G., Puttaraju M., Zhang Y., Zhou W., Cohn J.A., Garcia-Blanco M.A., Mitchell L.G., Engelhardt J.F. Partial correction of endogenous ΔF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20:2002;47-52.
128. S. Gersting, C. Rudolph, P. Nicklaus, C. Plank, J. Rosenecker, Magnetofection of permanent and primary human airway epithelial cells, Mol. Ther. 3 (No. 5, Part 2 of 2 Parts) (2001) Abstr. 1017.
129. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., Gansbacher B., Plank C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9:2002;102-109.
130. Boyle M.P., Enke R.A., Adams R.J., Guggino W.B., Zeitlin P.L. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol. Ther. 4:2001;115-121.
131. Lipshutz G.S., Flebbe-Rehwaldt L., Gaensler K.M.L. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration. Mol. Ther. 2:2000;374-380.
132. Larson J.E., Morrow S.L., Delcarpio J.B., Bohm R.P., Ratterree M.S., Blanchard J.L., Cohen J.C. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol. Ther. 2:2000;631-639.
133. Larson J.E., Delcarpio J.B., Farberman M.M., Morrow S.L., Cohen J.C. CFTR modulates lung secretory cell proliferation and differentiation. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L333-L341.
134. Q. Jiang, Z. Li, Y. Zhang, J.F. Engelhardt, Development of a ferret model of the cystic fibrosis, Pediatr. Pulmonol. Suppl. 20 (2000) Abstr. 164.
135. Harris A. Towards an ovine model of cystic fibrosis. Hum. Mol. Genet. 6:1997;2191-2194.
136. C. Rooney, M. Suter, M. Donnelly, J. Reinhardt, A. Delsing, E.A. Hoffman, G. McLennan, J. Zabner, Laser induced fluorescence bronchoscopy for the detection of gene transfer, Mol. Ther. 3 (No. 5, Part 2 of 2 Parts) (2001) Abstr. 1152.